Results 141 to 150 of about 4,089,932 (351)

LOXHD1 and RHOB Expression by Monocytes Predicts Progressive Systemic Sclerosis associated Interstitial Lung Disease

Arthritis Care &Research, Accepted Article.
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla, Robert Lafyatis, Kevin F Gibson, Christina Morse, Eleanor Valenzi, Xiaoping Chen, Xiaoyun Li, Yanwu Zhao, Yongseok Park, Dana Ascherman, Jonathan Minden, Robyn Domsic, Yingze Zhang, Daniel J Kass   +13 more
wiley   +1 more source

Pleural clinic: where thoracic ultrasound meets respiratory medicine. [PDF]

Front Med (Lausanne), 2023
Tinè M, Daverio M, Semenzato U, Cocconcelli E, Bernardinello N, Damin M, Saetta M, Spagnolo P, Balestro E.   +8 more
europepmc   +1 more source

Evidence-based medicine in the therapy of the acute respiratory distress syndrome [PDF]

, 2002
Rüdger Kopp, Ralf Kuhlen, Martin Max, Rolf Rossaint   +3 more
openalex   +1 more source

Respiratory medicine: the casualties. [PDF]

BMJ, 1992
P. Dilworth, T. Howes, L. Restrick, M. Iredale, M. Sanderson, J. Meecham-Jones   +5 more
openaire   +3 more sources

Heterogeneity of Rheumatoid Arthritis‐Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations with Disease Outcomes

Arthritis Care &Research, Accepted Article.
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis‐associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999‐2021. RA‐ILD patients were
Bryant R. England, Yangyuna Yang, Punyasha Roul, Tate M. Johnson, Scott M. Matson, Grant W. Cannon, Brian C. Sauer, Jeffrey R. Curtis, Joshua F. Baker, Ted R. Mikuls   +9 more
wiley   +1 more source

Relapse of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Despite Maintenance Treatment With Low‐Dose Mepolizumab

Respirology Case Reports
We present the case of an ANCA+ EGPA patient with a long disease history and remission for over 8 years (between 2015 and 2023), who developed a life‐threatening relapse marked by diffuse alveolar haemorrhage and mononeuritis multiplex despite low dose ...
Aurelie Vanthuyne, Sebastian Riemann, Guy Brusselle   +2 more
doaj   +1 more source

Practical Paediatric Respiratory Medicine: Edited by M Silverman, C L O'Callaghan. London: Arnold, 2001, pound39.50, pp 293 (paperback). ISBN 0 340 74126 0 [PDF]

, 2002
Mark L. Everard
openalex   +1 more source

Technology in respiratory medicine

Continuing Medical Education, 2003
No Abstract.
openaire   +2 more sources

Effectiveness and safety of baricitinib for juvenile idiopathic arthritis associated uveitis or chronic anterior antinuclear antibody positive uveitis

Arthritis Care &Research, Accepted Article.
Objectives Evaluate the efficacy and safety of baricitinib in paediatric patients with active JIA‐U or chronic anterior ANA‐positive uveitis, who had an inadequate response to MTX or bDMARDs. Methods JUVE‐BRIGHT was an open‐label, active‐controlled, Phase‐3 multicentre trial which utilized a novel design, including 1:1 randomization to an active ...
Athimalaipet V. Ramanan, Catherine M. Guly, Gabriele Simonini, Stuart Keller, Priyanka Sen, Thorsten Holzkaemper, Joana Araújo, Pierre Quartier   +7 more
wiley   +1 more source

Stop Thinking! I Can't! Do Attentional Mechanisms Underlie Primary Dysfunctional Breathing?

Frontiers in Physiology, 2018
Laís S. Vidotto, Marcelo Bigliassi, Mandy O. Jones, Alex Harvey, Celso R. F. Carvalho   +4 more
doaj   +1 more source